2015 Q1 Form 10-Q Financial Statement

#000114420415029729 Filed on May 12, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q1
Revenue $809.2K $798.4K
YoY Change 1.34% 8.01%
Cost Of Revenue $630.8K $450.2K
YoY Change 40.11% 33.45%
Gross Profit $178.3K $348.2K
YoY Change -48.78% -13.35%
Gross Profit Margin 22.04% 43.61%
Selling, General & Admin $3.292M $844.2K
YoY Change 290.01% 22.09%
% of Gross Profit 1846.24% 242.47%
Research & Development $514.7K $397.4K
YoY Change 29.51% 25.1%
% of Gross Profit 288.62% 114.15%
Depreciation & Amortization $59.64K $99.71K
YoY Change -40.18% 1.38%
% of Gross Profit 33.44% 28.64%
Operating Expenses $3.867M $1.341M
YoY Change 188.28% 21.12%
Operating Profit -$3.688M -$993.2K
YoY Change 271.39% 40.74%
Interest Expense $51.50K $38.49K
YoY Change 33.8% -78.6%
% of Operating Profit
Other Income/Expense, Net -$1.402M $2.505M
YoY Change -155.98% -1186.21%
Pretax Income -$5.091M $1.512M
YoY Change -436.72% -261.48%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$5.091M $1.512M
YoY Change -436.72% -261.48%
Net Earnings / Revenue -629.16% 189.36%
Basic Earnings Per Share -$0.40 $0.15
Diluted Earnings Per Share -$0.40 $0.13
COMMON SHARES
Basic Shares Outstanding 13.56M shares 9.972M shares
Diluted Shares Outstanding 13.56M shares 11.52M shares

Balance Sheet

Concept 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $22.90M $300.0K
YoY Change 7533.33% -40.0%
Cash & Equivalents $22.88M $271.8K
Short-Term Investments
Other Short-Term Assets $400.0K $100.0K
YoY Change 300.0% -66.67%
Inventory $1.000M $1.036M
Prepaid Expenses
Receivables $300.0K $187.8K
Other Receivables $0.00 $0.00
Total Short-Term Assets $24.50M $1.560M
YoY Change 1470.33% -8.22%
LONG-TERM ASSETS
Property, Plant & Equipment $400.0K $415.8K
YoY Change -3.8% -30.7%
Goodwill
YoY Change
Intangibles $494.7K
YoY Change
Long-Term Investments
YoY Change
Other Assets $101.1K
YoY Change
Total Long-Term Assets $1.700M $1.432M
YoY Change 18.74% 2.26%
TOTAL ASSETS
Total Short-Term Assets $24.50M $1.560M
Total Long-Term Assets $1.700M $1.432M
Total Assets $26.20M $2.992M
YoY Change 775.7% -3.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $800.0K $2.274M
YoY Change -64.82% -28.94%
Accrued Expenses $700.0K $540.6K
YoY Change 29.49% -32.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $200.0K
YoY Change -100.0% -60.0%
Long-Term Debt Due $80.10K $99.32K
YoY Change -19.35% -92.36%
Total Short-Term Liabilities $1.700M $3.397M
YoY Change -49.95% -48.54%
LONG-TERM LIABILITIES
Long-Term Debt $1.077M $168.3K
YoY Change 539.77% -90.1%
Other Long-Term Liabilities $300.0K $8.400M
YoY Change -96.43% 366.67%
Total Long-Term Liabilities $1.077M $8.558M
YoY Change -87.42% 144.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.700M $3.397M
Total Long-Term Liabilities $1.077M $8.558M
Total Liabilities $3.100M $11.95M
YoY Change -74.07% 18.36%
SHAREHOLDERS EQUITY
Retained Earnings -$34.78M
YoY Change
Common Stock $10.24K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.10M -$8.963M
YoY Change
Total Liabilities & Shareholders Equity $26.20M $2.992M
YoY Change 775.7% -3.49%

Cashflow Statement

Concept 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income -$5.091M $1.512M
YoY Change -436.72% -261.48%
Depreciation, Depletion And Amortization $59.64K $99.71K
YoY Change -40.18% 1.38%
Cash From Operating Activities -$2.748M -$1.073M
YoY Change 156.03% 314.4%
INVESTING ACTIVITIES
Capital Expenditures $18.31K $57.01K
YoY Change -67.88% 529.86%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$26.22K -$348.9K
YoY Change -92.49% 1184.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $100.8K $55.50K
YoY Change 81.64% -53.54%
Cash From Financing Activities $25.57M $1.384M
YoY Change 1747.95% 84.02%
NET CHANGE
Cash From Operating Activities -$2.748M -$1.073M
Cash From Investing Activities -$26.22K -$348.9K
Cash From Financing Activities $25.57M $1.384M
Net Change In Cash $22.80M -$38.33K
YoY Change -59584.82% -108.23%
FREE CASH FLOW
Cash From Operating Activities -$2.748M -$1.073M
Capital Expenditures $18.31K $57.01K
Free Cash Flow -$2.766M -$1.130M
YoY Change 144.73% 321.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
416965 USD
CY2015Q1 us-gaap Notes Payable
NotesPayable
0 USD
CY2015Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
80097 USD
CY2015Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
11629 USD
CY2015Q1 us-gaap Customer Deposits Current
CustomerDepositsCurrent
19057 USD
CY2015Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1077009 USD
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1088996 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
1959449 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-5090852 USD
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
3866799 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-993150 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3688466 USD
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
49626 shares
CY2015Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
49626 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15865141 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11295387 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15865141 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11295387 shares
CY2015Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
113084 USD
CY2015Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
695574 USD
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
798418 USD
CY2014Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
390649 USD
CY2015Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
585390 USD
CY2014Q1 us-gaap Cost Of Services
CostOfServices
59600 USD
CY2015Q1 us-gaap Cost Of Services
CostOfServices
45432 USD
CY2014Q1 us-gaap Cost Of Revenue
CostOfRevenue
450249 USD
CY2015Q1 us-gaap Cost Of Revenue
CostOfRevenue
630822 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
348169 USD
CY2015Q1 us-gaap Gross Profit
GrossProfit
178333 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
397422 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
514707 USD
CY2014Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
364555 USD
CY2015Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
357547 USD
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
479637 USD
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2934907 USD
CY2014Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
99705 USD
CY2015Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
59638 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
1341319 USD
CY2015Q1 vuzi Class Of Warrant Or Right Exercised In Period
ClassOfWarrantOrRightExercisedInPeriod
4699017 shares
CY2014Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3951 USD
CY2015Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
5271 USD
CY2014Q1 us-gaap Interest Expense
InterestExpense
38487 USD
CY2015Q1 us-gaap Interest Expense
InterestExpense
51496 USD
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2505056 USD
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1402386 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1511906 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5090852 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
1511906 USD
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2014Q1 us-gaap Depreciation
Depreciation
99705 USD
CY2015Q1 us-gaap Depreciation
Depreciation
59639 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
19347 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
113084 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-27130 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-128407 USD
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
82047 USD
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
101518 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-136026 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-164821 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-146719 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1355578 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-13700 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-25330 USD
CY2014Q1 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-72409 USD
CY2015Q1 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-101493 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
10678 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-6060 USD
CY2014Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
5708 USD
CY2015Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
22470 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1073311 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2747955 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
57009 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18310 USD
CY2014Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
11305 USD
CY2015Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
7909 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-348899 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26219 USD
CY2014Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
0 USD
CY2015Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-112500 USD
CY2014Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
8042 USD
CY2015Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
5253 USD
CY2014Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
55501 USD
CY2015Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
100813 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1383882 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25573516 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-38328 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
22799342 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
310140 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
271812 USD
CY2014Q1 us-gaap Interest Paid
InterestPaid
32779 USD
CY2015Q1 us-gaap Interest Paid
InterestPaid
17794 USD
CY2015Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px 0px 0px 34.55pt; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; MARGIN: 0px 0px 0px 0in; FONT: 10pt Times New Roman, Times, Serif"> <b><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Note&#160;1&#160;&#151; Basis of Presentation</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; MARGIN: 0px 0px 0px 34.55pt; FONT: 10pt Times New Roman, Times, Serif"> <b>&#160;</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0px 0px 0px 0in; FONT: 10pt Times New Roman, Times, Serif"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0px 0px 0px 0in"> The accompanying unaudited Condensed Consolidated Financial Statements of Vuzix Corporation and Subsidiaries (&#8220;the Company") have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission. Accordingly, the unaudited Condensed Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. The condensed consolidated balance sheet as of December 31, 2014 was derived from the audited Consolidated Financial Statements in Form 10-K.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0px 0px 0px 0.5in"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0px 0px 0px 0in"> The accompanying Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of the Company as of December 31, 2014, as reported in the Company&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0px 0px 0px 0.5in"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0px 0px 0px 0in"> The results of the Company&#8217;s operations for any interim period are not necessarily indicative of the results of the Company&#8217;s operations for any other interim period or for a full fiscal year.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
1251224 USD
CY2014Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
25974 USD
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
300889 USD
CY2014Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
666138 USD
CY2015Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
91134 USD
CY2014Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
101445 USD
CY2015Q1 vuzi Accrued Compensation
AccruedCompensation
417286 USD
CY2014Q4 vuzi Accrued Compensation
AccruedCompensation
428786 USD
CY2015Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
33500 USD
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
45000 USD
CY2015Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
45623 USD
CY2014Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
39624 USD
CY2015Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1003 USD
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8741 USD
CY2014Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
39624 USD
CY2015Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
21948 USD
CY2015Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
27947 USD
CY2015Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
45623 USD
CY2015Q1 us-gaap Long Term Debt
LongTermDebt
1157106 USD
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
1217421 USD
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5236660 shares
CY2015Q1 vuzi Class Of Warrant Or Right Grants In Period
ClassOfWarrantOrRightGrantsInPeriod
60000 shares
CY2015Q1 vuzi Class Of Warrant Or Right Expired In Period
ClassOfWarrantOrRightExpiredInPeriod
0 shares
CY2015Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
597643 shares
CY2015Q1 vuzi Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Terms
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerms
P2Y10M24D
CY2015Q1 invest Investment Warrants Exercise Price
InvestmentWarrantsExercisePrice
2.56
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
720551 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2015Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
720551 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.46
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.46
CY2014Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
1.71
CY2014Q4 vuzi Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperLimit
17.50
CY2015Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
1.71
CY2015Q1 vuzi Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Balance
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitBalance
17.50
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y10M24D
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
304337 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.95
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
416214 shares
CY2015Q1 vuzi Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice
2.63
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P9Y3M18D
CY2015Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
957291 USD
CY2015Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
CY2015Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
114088 USD
CY2015Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
59143 USD
CY2015Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
2037500 USD
CY2015Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
175158 USD
CY2014Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
13541138 USD
CY2014Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
2575262 USD
CY2015Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-1003427 USD
CY2014Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
6326 USD
CY2015Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
340960 USD
CY2015Q1 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
0 USD
CY2014Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
0 USD
CY2015Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0 USD
CY2014Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
0 USD
CY2015Q1 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
175158 USD
CY2014Q4 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
13541138 USD
CY2014Q1 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
0 USD
CY2015Q1 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
11453 USD
CY2014Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2575262 USD
CY2015Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1003427 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 USD
CY2015Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
24813000 USD
CY2015Q1 vuzi Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
1200751 USD
CY2015Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
716126 USD
CY2014Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
787738 USD
CY2015Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
68489 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
53403 USD
CY2015Q1 vuzi Share Based Compensation Arrangement By Share Based Payment Award Options Granted Exercise Price Range
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedExercisePriceRange
0
CY2015Q1 vuzi Share Based Compensation Shares Authorized Under Stock Option Plans Exercised In Period Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisedInPeriodExercisePriceRange
0
CY2015Q1 vuzi Adjustment To Addional Paid In Capital Reclassification Of Warrant Liability
AdjustmentToAddionalPaidInCapitalReclassificationOfWarrantLiability
8736412 USD
CY2015Q1 vuzi Adjustment To Addional Paid In Capital Reclassification Of Warrant Exercises
AdjustmentToAddionalPaidInCapitalReclassificationOfWarrantExercises
2826053 USD
CY2014Q1 us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
280585 USD
CY2015Q1 us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
0 USD
CY2014Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1447425 USD
CY2015Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1200751 USD
CY2014Q1 us-gaap Taxes Other
TaxesOther
21442 USD
CY2015Q1 us-gaap Taxes Other
TaxesOther
11774 USD
CY2014Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2015Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
221669 USD
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
101068 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
112521 USD
CY2015Q1 vuzi Officers Compensation Payable Compounding Monthly Interest Rate
OfficersCompensationPayableCompoundingMonthlyInterestRate
0.08 pure
CY2015Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
386036 USD
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
393526 USD
CY2015Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
71076 USD
CY2014Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
62801 USD
CY2015Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
52600 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
4730992 shares
CY2014Q4 us-gaap Convertible Debt
ConvertibleDebt
3000000 USD
CY2014Q2 vuzi Fair Value Of Debt Embedded Conversion Price Adjustment Option
FairValueOfDebtEmbeddedConversionPriceAdjustmentOption
1938988 USD
CY2015Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2210731 USD
CY2015Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1053625 USD
CY2015Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
337500 USD
CY2015Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
235500 USD
CY2014Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
CY2015Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
526916 USD
CY2014Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 USD
CY2015Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
71613 USD
CY2014Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
CY2015Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
15086 USD
CY2014Q1 vuzi Common Stock Issued And Warrant Issued For Services Prepaid Expense
CommonStockIssuedAndWarrantIssuedForServicesPrepaidExpense
0 USD
CY2015Q1 vuzi Common Stock Issued And Warrant Issued For Services Prepaid Expense
CommonStockIssuedAndWarrantIssuedForServicesPrepaidExpense
138625 USD
CY2014Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6326 USD
CY2015Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
340960 USD
CY2015Q1 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
85191 USD
CY2014Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
75471 USD
CY2015Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
0 USD
CY2014Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
2806942 USD
CY2015Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
175158 USD
CY2014Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
10734196 USD
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1544999 shares
CY2014 us-gaap Earnings Per Share Potentially Dilutive Securities
EarningsPerSharePotentiallyDilutiveSecurities
7,012,767
CY2015Q1 us-gaap Earnings Per Share Potentially Dilutive Securities
EarningsPerSharePotentiallyDilutiveSecurities
7,186,350
CY2015Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1475000 USD
CY2015Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
260373 USD
CY2015Q1 vuzi Adjustments To Additional Paid In Capital Reclassification Of Fair Value Of Note Derivative Liability
AdjustmentsToAdditionalPaidInCapitalReclassificationOfFairValueOfNoteDerivativeLiability
2806942 USD
CY2015Q1 vuzi Adjustments To Additional Paid In Capital Proceeds From Preferred Stock Offering Value
AdjustmentsToAdditionalPaidInCapitalProceedsFromPreferredStockOfferingValue
24813000 USD
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
CY2015Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
221669 USD
CY2014Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0 USD
CY2015Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
358939 USD
CY2014Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1511906 USD
CY2015Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5449791 USD
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9972105 shares
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13561206 shares
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11517104 shares
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13561206 shares
CY2015Q1 us-gaap Contractual Obligation
ContractualObligation
66800 USD
CY2015Q1 us-gaap Description Of Lessor Leasing Arrangements Operating Leases
DescriptionOfLessorLeasingArrangementsOperatingLeases
The Company leases office and manufacturing space under operating leases that expire on September 30, 2015 through to March 1, 2016.
CY2014Q1 vuzi Common Stock Awards Compensation Expense
CommonStockAwardsCompensationExpense
0 USD
CY2015Q1 vuzi Common Stock Awards Compensation Expense
CommonStockAwardsCompensationExpense
1475000 USD
CY2015Q1 vuzi Share Based Compensation Shares Authorized Under Stock Option Plans Forfeitures And Expirations In Period Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansForfeituresAndExpirationsInPeriodExercisePriceRange
0
CY2014Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
CY2015Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
337500 USD
CY2014Q1 vuzi Reclassification Of Derivative Liability To Paidin Capital Upon Waiver Of Certain Antidilutive Provisions Of Warrants And Convertible Debt
ReclassificationOfDerivativeLiabilityToPaidinCapitalUponWaiverOfCertainAntidilutiveProvisionsOfWarrantsAndConvertibleDebt
0 USD
CY2015Q1 vuzi Reclassification Of Derivative Liability To Paidin Capital Upon Waiver Of Certain Antidilutive Provisions Of Warrants And Convertible Debt
ReclassificationOfDerivativeLiabilityToPaidinCapitalUponWaiverOfCertainAntidilutiveProvisionsOfWarrantsAndConvertibleDebt
11543354 USD
CY2014Q1 vuzi Reclassification Of Derivative Liability Upon Warrant Exercises
ReclassificationOfDerivativeLiabilityUponWarrantExercises
0 USD
CY2015Q1 vuzi Reclassification Of Derivative Liability Upon Warrant Exercises
ReclassificationOfDerivativeLiabilityUponWarrantExercises
2826053 USD
CY2015Q1 us-gaap Interest Payable Current
InterestPayableCurrent
8994 USD
CY2014Q4 us-gaap Interest Payable Current
InterestPayableCurrent
7338 USD
CY2015Q1 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
1000
CY2015Q1 vuzi Preferred Stock Shares Outstanding In Percent Liquidation Or Amendment Actions
PreferredStockSharesOutstandingInPercentLiquidationOrAmendmentActions
0.6 pure

Files In Submission

Name View Source Status
0001144204-15-029729-index-headers.html Edgar Link pending
0001144204-15-029729-index.html Edgar Link pending
0001144204-15-029729.txt Edgar Link pending
0001144204-15-029729-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v409290_10q.htm Edgar Link pending
v409290_ex31-1.htm Edgar Link pending
v409290_ex31-2.htm Edgar Link pending
v409290_ex32-1.htm Edgar Link pending
v409290_ex32-2.htm Edgar Link pending
vuzi-20150331.xml Edgar Link completed
vuzi-20150331.xsd Edgar Link pending
vuzi-20150331_cal.xml Edgar Link unprocessable
vuzi-20150331_def.xml Edgar Link unprocessable
vuzi-20150331_lab.xml Edgar Link unprocessable
vuzi-20150331_pre.xml Edgar Link unprocessable